Delivery Order 36F79722D0197-36C26226N0361
Award Date 2/12/26
Potential Completion Date 6/30/26
Potential Value $335K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Telix Pharmaceuticals US Inc. was awarded a $666.8K firm fixed-price delivery order by Veterans Integrated Service Network 22 (VISN 22), a Veterans Affairs entity, for Illuccix PSMA radiopharmaceutical products. The delivery order, issued on February 11, 2025, with an ultimate completion date of February 11, 2026, carries no small business set-aside designation. Performance will occur in Dublin, Ohio. Illuccix is a specialized diagnostic radiopharmaceutical used for prostate cancer imaging in...
- Telix Pharmaceuticals US Inc. has been awarded a $479,500 firm fixed price delivery order against a Blanket Purchase Agreement to provide radiopharmaceutical Illuccix for prostate cancer imaging services. The order was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 located in Dublin, Ohio, with a completion date of November 6, 2023. As a manufacturer of radiopharmaceutical goods, Telix Pharmaceuticals supports nuclear medicine...
- This is a firm fixed price delivery order awarded to Telix Pharmaceuticals US Inc. by the Department of Veterans Affairs (VA) in the amount of $334,300.00. The award is for the delivery of Illuccix, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine and medical imaging services. The award was issued under Telix's existing $17.5 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, as well as the company's other contract...
- Telix Pharmaceuticals US Inc., headquartered in Fishers, Indiana, received a $1.14M firm fixed-price Blanket Purchase Agreement (BPA) call order from Veterans Integrated Service Network 8 (VISN 8), a civilian agency under the Department of Veterans Affairs, with an award date of October 1, 2024, and an ultimate completion date of September 30, 2025. This contract, which carries no set-aside designation, is for the supply of Illuccix, an advanced radiopharmaceutical product used for prostate...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded a $99,000 firm fixed-price delivery order to Telix Pharmaceuticals US Inc. for GA68 PSMA Injection on October 25, 2024. This delivery order, with an ultimate completion date of October 24, 2025, does not utilize a small business set-aside designation. The contract represents a call order against Telix Pharmaceuticals' existing federal supply agreements for radiopharmaceutical products, with...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Telix Pharmaceuticals US Inc., a for-profit manufacturer of goods. The $161,700 contract is for the supply of Telix's radiopharmaceutical products, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures, to VA medical facilities through February 2025. This award is part of a larger $17.5 million Blanket Purchase Agreement (BPA) the VA awarded Telix in...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) has awarded Telix Pharmaceuticals US Inc. a Blanket Purchase Agreement (BPA) call order valued at $857.5K for the supply of various radiopharmaceuticals. The contract, effective October 1, 2025, with an ultimate completion date of September 30, 2026, operates as a firm fixed-price delivery order without small business set-aside designation. Telix Pharmaceuticals, headquartered in Fishers, Indiana, will perform the...
- This is a federal contract award to Telix Pharmaceuticals US Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) through its Veterans Health Administration (VHA). The contract, with a ceiling value of $858,000.00, is for the delivery of various radiopharmaceuticals to support the VA's nuclear medicine and medical imaging services for veterans. The contract is a Blanket Purchase Agreement (BPA) call order awarded under a larger $17.5 million BPA the company...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Telix Pharmaceuticals US Inc., a global commercial-stage biopharmaceutical company that manufactures diagnostic and therapeutic radiopharmaceutical products. The $774,700.00 call order is for the supply of various radiopharmaceuticals, including Illuccix for prostate cancer imaging and Gozetotide for other nuclear medicine procedures,...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $665,200 firm fixed price delivery order contract to Telix Pharmaceuticals US Inc. to provide ILLUCCIX (MEDICATION) ORDER. The contract has a period of performance from July 11, 2022 through October 31, 2022 and will be performed at the VETERANS ADMINISTRATION facility located in West Los Angeles, California.</p>